PURSUIT VASCULAR

Pursuit Vascular, Inc., a private company with headquarters in Minneapolis, MN, is focused on developing innovative catheter infection reduction technologies. The company is developing a family of innovative single-use products intended to protect patients from life-threatening infections and provide substantial savings to the global healthcare system. The Centers for Disease Control has identified catheter-related bloodstream infections (CRBSI) as one of its seven major healthcare challenges; with mortality rates up to 25% and economic costs in the billions of dollars. In the US alone, nearly 500,000 new cases of CRBSI are reported each year, with costs exceeding $3 billion. The need for improvement is compelling and urgent.